The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Dolutegravir’s first bump in the road to global roll-out begs larger questions around women’s rights and access to contraceptives at the International AIDS Conference (AIDS 2018).
As HIV drug resistance increases in low- and middle-income countries, getting people onto antiretroviral treatment means little in the long run if treatment programming is not also strengthened.
Testing for HIV is rising in the UK, but opportunities are being missed among some vulnerable groups.
South Africa’s national antiretroviral treatment programme has successfully reduced deaths and enabled people with HIV to maintain good health – but men are far less likely to benefit.
New research shows antiretroviral treatment radically reduces health inequalities – supporting arguments for scale-up of HIV treatment in low-resourced contexts.
A BMJ international panel made up of women living with HIV, specialist doctors, and general practitioners recommends non-tenofovir based treatment regimes for pregnant women living with HIV.
Young adults represent a growing proportion of the number of people living with HIV in the USA, but they are at high-risk of disengaging from care when transitioning from paediatric to adult services.
In the era of treat all, renewed emphasis is needed on the 39% of people living with HIV who start treatment late who are at an increased risk of deaths and opportunistic infections.
The number of men testing positive for HIV fell dramatically in England last year, revealing the remarkable impact of targeted interventions for men who have sex with men.
In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older